| Literature DB >> 27121876 |
Wei Dai1, Hong Zheng1, Arthur Kwok Leung Cheung2, Maria Li Lung3.
Abstract
Nasopharyngeal carcinoma (NPC) is a unique epithelial malignancy that shows a remarkable geographical and ethic distribution. Multiple factors including predisposing genetic factors, environmental carcinogens, and Epstein-Barr virus (EBV) infection contribute to the accumulation of genetic and epigenetic alterations leading to NPC development. Emerging technologies now allow us to detailedly characterize and understand cancer genomes. Genome-wide studies show that typically NPC tumors are characterized as having comparatively low mutation rates, widespread hypermethylation, and frequent copy number alterations and chromosome abnormalities. In this review, we provide an updated overview of the genetic and epigenetic aberrations that likely drive nasopharyngeal tumor development and progression. We integrate the previous knowledge and novel findings from whole-exome sequencing (WES) and methylome studies in NPC, and further discuss the potential use of these findings to identify biomarkers for NPC diagnosis and prognosis.Entities:
Keywords: Nasopharyngeal carcinoma (NPC); biomarkers; epigenetics; whole-exome sequencing (WES)
Mesh:
Substances:
Year: 2016 PMID: 27121876 DOI: 10.21037/cco.2016.03.06
Source DB: PubMed Journal: Chin Clin Oncol ISSN: 2304-3865